
Primary resistance to BCMA-targeted bispecifics in multiple myeloma, emapalumab therapy in hemophagocytic lymphohistiocytosis, and chemotherapy-induced pyroptosis as a mechanism of thrombus formation in patients with cancer
Blood Podcast
00:00
Exploring Resistance Mechanisms in Hematological Therapies and Chemotherapy-Induced Thrombosis
This chapter explores key developments in hematological treatments, focusing on resistance mechanisms in multiple myeloma and the promising outcomes of emipalumab for pediatric hemophagocytic lymphohistiocytosis. It also discusses the potential therapeutic applications of GSDME-mediated pyroptosis in reducing chemotherapy-related thrombotic risks.
Transcript
Play full episode